Translate instantly to 26 languages
Josh Dury Photo-Media
。关于这个话题，heLLoword翻译官方下载提供了深入分析
BioMarin也迅速跟进迭代研发，其升级版在研产品BMN333同样旨在实现周剂注射。早期临床结果显示BMN333的AUC水平高于其他长效CNP研究的3倍以上，公司研发主管Greg Friberg表示该药对标的正是TransCon-CNP。
Crawford - whose parent company is based in the US - was approached for comment, but the firm referred the BBC to the NHS.